| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Delgado-Moreira Juan | Co-Chief Executive Officer, Director, 10%+ Owner | C/O HAMILTON LANE INCORPORATED, 110 WASHINGTON STREET, SUITE 1300, CONSHOHOCKEN | /s/ Lauren Platko, attorney-in-fact | 10 Nov 2025 | 0001698040 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HLNE | Class A Common Stock | Purchase | $520K | +4.01K | +0.31% | $129.84 | 1.31M | 07 Nov 2025 | Direct | F1 |
| transaction | HLNE | Class A Common Stock | Purchase | $522K | +3.99K | +0.3% | $130.87 | 1.31M | 07 Nov 2025 | Direct | F2 |
| holding | HLNE | Class A Common Stock | 14.4K | 07 Nov 2025 | By Trust | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | HLNE | Performance Stock | 544K | 07 Nov 2025 | Class A Common Stock | 544K | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.50 to $130.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote. |
| F2 | The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.53 to $131.26, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote. |
| F3 | These securities are held in trust for the benefit of the reporting person. |
| F4 | Each share of performance stock represents a contingent right to receive one share of Class A common stock. The performance stock vests upon the Issuer's Class A common stock achieving a specified price per share. The performance period of the performance stock ends on September 16, 2031. |
In addition to serving as an officer and director of the Issuer, the reporting person is a member of a group that beneficially owns more than 10% of the Issuer's Class A common stock.